A Prospective Evaluation Of The Radiographic Efficacy Of Etanercept In Patients With Rheumatoid Arthritis Or Psoriatic Arthritis
Phase of Trial: Phase IV
Latest Information Update: 04 Aug 2015
At a glance
- Drugs Etanercept (Primary)
- Indications Psoriatic arthritis; Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms PRERA
- Sponsors Pfizer
- 07 Jun 2017 Biomarkers information updated
- 30 Jul 2015 Planned End Date changed from 1 Feb 2018 to 1 Apr 2018, as reported by ClinicalTrials.gov.
- 30 Jul 2015 Planned primary completion date changed from 1 Feb 2018 to 1 Apr 2018, as reported by ClinicalTrials.gov.